Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
pSivida (ASX😛VA) has announced that the first UK National Health Service (NHS) patient has been treated with Iluvien, less than three months after the product was recommended for reimbursement for a subset of diabetic macular edema (DME) patients.
pSivida?s licensee Alimera Sciences has shipped initial Iluvien orders to several UK NHS facilities, and the first patient was implanted on 10 January.
The UK?s National Institute for Health and Care Excellence (NICE) issued a final guidance to the National Health Service on 27 November, recommending Iluvien for chronic DME patients who have already had cataract surgery and are considered insufficiently responsive to available therapies.
http://lifescientist.com.au/content...tient-treated-with-iluvien-psivida-1092518736
pSivida?s licensee Alimera Sciences has shipped initial Iluvien orders to several UK NHS facilities, and the first patient was implanted on 10 January.
The UK?s National Institute for Health and Care Excellence (NICE) issued a final guidance to the National Health Service on 27 November, recommending Iluvien for chronic DME patients who have already had cataract surgery and are considered insufficiently responsive to available therapies.
http://lifescientist.com.au/content...tient-treated-with-iluvien-psivida-1092518736